Population pharmacokinetics and pharmacodynamics of doripenem in obese patients.

被引：0
|
作者：
Chung, Eun Kyoung [1 ]
Cheatham, S. Christian [2 ]
Fleming, Megan R. [3 ]
Kays, Michael B. [1 ]
机构：
[1] Purdue Univ, Coll Pharm, Dept Pharm Practice, Indianapolis, IN USA
[2] Franciscan St Francis Hlth Indianapolis, Dept Pharm, Indianapolis, IN USA
[3] Methodist Dallas Med Ctr, Dallas, TX USA
来源：
PHARMACOTHERAPY | 2013年 / 33卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
125
引用
收藏
页码：E220 / E220
页数：1
相关论文
共 50 条
  • [31] The pharmacokinetics and pharmacodynamics of enoxaparin in obese volunteers
    Sanderink, GJ
    Le Liboux, A
    Jariwala, N
    Harding, N
    Ozoux, ML
    Shukla, U
    Montay, G
    Boutouyrie, B
    Miro, A
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2002, 72 (03) : 308 - 318
  • [32] PHARMACOKINETICS AND PHARMACODYNAMICS OF PREDNISOLONE IN OBESE RATS
    NICHOLS, AI
    DAMBROSIO, R
    PYSZCZYNSKI, NA
    JUSKO, WJ
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 1989, 250 (03): : 963 - 970
  • [33] The Importance of Assessing Drug Pharmacokinetics and Pharmacodynamics in the Obese Population During Drug Development
    Moore, Kenneth T.
    Zannikos, Peter N.
    Masters, Joanna C.
    Willmann, Stefan
    Shen, Jinshan
    Frost, Charles
    JOURNAL OF CLINICAL PHARMACOLOGY, 2023, 63 : S78 - S84
  • [34] Population pharmacokinetics and pharmacodynamics of cysteamine in nephropathic cystinosis patients
    Naïm Bouazza
    Jean-Marc Tréluyer
    Chris Ottolenghi
    Saik Urien
    Georges Deschenes
    Daniel Ricquier
    Patrick Niaudet
    Bernadette Chadefaux-Vekemans
    Orphanet Journal of Rare Diseases, 6
  • [35] Population pharmacokinetics and pharmacodynamics of imipenem in neutropenic adult patients
    Lafaurie, M.
    Burdet, C.
    Hammas, K.
    Goldwirt, L.
    Bercot, B.
    Sauvageon, H.
    Houze, P.
    Fourmont, M.
    Mentre, F.
    Molina, J. M.
    INFECTIOUS DISEASES NOW, 2023, 53 (01):
  • [36] Population pharmacokinetics and pharmacodynamics of cysteamine in nephropathic cystinosis patients
    Bouazza, Naim
    Treluyer, Jean-Marc
    Ottolenghi, Chris
    Urien, Saik
    Deschenes, Georges
    Ricquier, Daniel
    Niaudet, Patrick
    Chadefaux-Vekemans, Bernadette
    ORPHANET JOURNAL OF RARE DISEASES, 2011, 6
  • [37] Population Pharmacokinetics and Pharmacodynamics of Pegozafermin in Patients with Nonalcoholic Steatohepatitis
    Tseng, Chih-Ming Leo
    Balic, Kemal
    Charlton, R. Will
    Margalit, Maya
    Mansbach, Hank
    Savic, Rada M.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2023, 114 (06) : 1323 - 1331
  • [38] Population pharmacokinetics and pharmacodynamics of meropenem in Japanese pediatric patients
    Ikawa, Kazuro
    Morikawa, Norifumi
    Ikeda, Kayo
    Miki, Mizuka
    Kobayashi, Masao
    JOURNAL OF INFECTION AND CHEMOTHERAPY, 2010, 16 (02) : 139 - 143
  • [39] Population pharmacokinetics and pharmacodynamics of oral levodopa in parkinsonian patients
    Triggs, EJ
    Charles, BG
    Contin, M
    Martinelli, P
    Cortelli, P
    Riva, R
    Albani, F
    Baruzzi, A
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1996, 51 (01) : 59 - 67
  • [40] ETHNIC SENSITIVITY ASSESSMENT OF CANAKINUMAB PHARMACOKINETICS AND PHARMACODYNAMICS IN GOUTY ARTHRITIS PATIENTS.
    Roberts, J.
    Tannenbaum, S.
    Sunkara, G.
    Chakraborty, A.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2012, 91 : S127 - S127
12345